UCB S.A./ BE0003739530 /
20/05/2024 12:35:01 | Var. +2.000 | Volume | Denaro12:35:01 | Lettera12:35:01 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
126.050EUR | +1.61% | - Fatturato: - |
126.050Quantità in denaro: - | 126.150Quantità in lettera: - | 23.99 bill.EUR | 1.08% | 69.75 |
GlobeNewswire
12:35
Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meet...
GlobeNewswire
12:30
Scorpio Tankers Inc. Announces Agreement for a $223.6 Million Prepayment under its 2023 $1.0 Billion...
GlobeNewswire
12:30
Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Tria...
GlobeNewswire
12:30
Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
GlobeNewswire
12:00
PAYCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating Paycom Software, Inc. on Behalf of Long-T...
GlobeNewswire
12:00
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Preventio...
GlobeNewswire
12:00
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene...
GlobeNewswire
12:00
Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan for the Treatment for Hypercholesterol...
GlobeNewswire
11:01
VEON’s Banglalink and Robi Axiata Partner to Explore Network Sharing to Expand 4G Access in Banglade...